[go: up one dir, main page]

MX2010002735A - Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno. - Google Patents

Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.

Info

Publication number
MX2010002735A
MX2010002735A MX2010002735A MX2010002735A MX2010002735A MX 2010002735 A MX2010002735 A MX 2010002735A MX 2010002735 A MX2010002735 A MX 2010002735A MX 2010002735 A MX2010002735 A MX 2010002735A MX 2010002735 A MX2010002735 A MX 2010002735A
Authority
MX
Mexico
Prior art keywords
neramexane
treatment
titration
amino
present
Prior art date
Application number
MX2010002735A
Other languages
English (en)
Inventor
Erhard Seiller
Michael Althaus
Barbara Ellers-Lenz
Tanja Rosenberg
Hagen Krueger
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of MX2010002735A publication Critical patent/MX2010002735A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invenci?n se refiere a un esquema de titulaci?n para la administraci?n de un derivado de 1-amino-alquilciclohexano, el cual permite la obtenci?n r?pida de una dosis efectiva de un derivado de 1- amino-alquilciclohexano mientras se minimizan los efectos secundarios. La presente invenci?n se refiere adem?s a un envase de titulaci?n para proporcionar un derivado de 1-amino-alquilciclohexano (por ejemplo, neramexano o una sal farmac?uticamente aceptable del mismo) en por lo menos dos dosis diferentes. El presente esquema de titulaci?n/envase de titulaci?n puede ser ?til en el tratamiento de varias enfermedades, incluyendo tinnitus.
MX2010002735A 2007-09-12 2008-09-10 Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno. MX2010002735A (es)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US99339607P 2007-09-12 2007-09-12
EP07253630 2007-09-12
US6702608P 2008-02-25 2008-02-25
US6693108P 2008-02-25 2008-02-25
US6708308P 2008-02-25 2008-02-25
EP08004778 2008-03-14
EP08004777 2008-03-14
EP08004776 2008-03-14
PCT/EP2008/007420 WO2009033651A1 (en) 2007-09-12 2008-09-10 Titration package for neramexane and its use in the treatment of an inner ear disorder

Publications (1)

Publication Number Publication Date
MX2010002735A true MX2010002735A (es) 2010-04-01

Family

ID=40451596

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2010002733A MX2010002733A (es) 2007-09-12 2008-09-10 Terapia de intervalo para el tratamiento de tinnitus.
MX2010002736A MX2010002736A (es) 2007-09-12 2008-09-10 Derivados de 1-amino-alquilciclohexano para el tratamiento de tinnitus coclear.
MX2010002734A MX2010002734A (es) 2007-09-12 2008-09-10 Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.
MX2010002735A MX2010002735A (es) 2007-09-12 2008-09-10 Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
MX2010002733A MX2010002733A (es) 2007-09-12 2008-09-10 Terapia de intervalo para el tratamiento de tinnitus.
MX2010002736A MX2010002736A (es) 2007-09-12 2008-09-10 Derivados de 1-amino-alquilciclohexano para el tratamiento de tinnitus coclear.
MX2010002734A MX2010002734A (es) 2007-09-12 2008-09-10 Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.

Country Status (21)

Country Link
US (6) US9498450B2 (es)
EP (6) EP2200600B1 (es)
JP (6) JP5563461B2 (es)
KR (4) KR20100052556A (es)
CN (4) CN101801365A (es)
AR (3) AR070025A1 (es)
AT (1) ATE532507T1 (es)
AU (4) AU2008298015B2 (es)
BR (2) BRPI0816712A2 (es)
CA (4) CA2699207A1 (es)
DK (1) DK2200600T3 (es)
ES (5) ES2596262T3 (es)
HR (1) HRP20120046T1 (es)
MX (4) MX2010002733A (es)
PL (1) PL2200600T3 (es)
PT (1) PT2200600E (es)
RU (1) RU2011137131A (es)
SI (1) SI2200600T1 (es)
TW (3) TW200922544A (es)
WO (4) WO2009033652A1 (es)
ZA (4) ZA201001264B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200922544A (en) * 2007-09-12 2009-06-01 Merz Pharma Gmbh & Amp Co Kgaa Interval therapy for the treatment of tinnitus
US20110294890A1 (en) * 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
EP2585049A1 (en) 2010-06-24 2013-05-01 Merz Pharma GmbH & Co. KGaA Neramexane multiple unit dosage form
JP6084931B2 (ja) * 2011-01-20 2017-02-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ストレス又は急性聴力損失に関連する耳鳴の治療又は予防のためのネラメキサン
AU2014225534A1 (en) * 2013-03-06 2015-09-24 Acorda Therapeutics, Inc. Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure
EA201692163A1 (ru) * 2014-04-28 2017-03-31 Керин Фармасьютикал Ко., Лтд. Лекарственное средство для лечения пациентов с тиннитусом
EA201692164A1 (ru) * 2014-04-28 2017-03-31 Керин Фармасьютикал Ко., Лтд. Лекарственное средство для лечения пациентов с тиннитусом
CA2999467C (en) * 2014-10-23 2023-10-10 Arena Pharmaceuticals, Inc. Method of treating conditions related to the pgi2 receptor
HUE056138T2 (hu) * 2015-05-18 2022-01-28 Sensorion Azasetron a halláskárosodás kezelésében való felhasználásra
KR101893604B1 (ko) 2015-08-27 2018-08-30 경희대학교 산학협력단 칸디다 유틸리스 추출물을 포함하는 난청의 예방 또는 치료용 조성물
CN105924362B (zh) * 2016-02-05 2018-08-17 上海龙翔生物医药开发有限公司 芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
WO2018160882A1 (en) 2017-03-01 2018-09-07 Arena Pharmaceuticals, Inc. Compositions comprising pgi2-receptor agonists and processes for the preparation thereof
KR102268893B1 (ko) 2020-01-16 2021-06-24 경북대학교 산학협력단 림노트릭스 속 knua002 균주를 포함하는 난청의 예방 또는 치료용 조성물
CN111477199B (zh) * 2020-04-02 2021-11-30 北京瑞迪欧文化传播有限责任公司 一种嵌入式音乐控制系统
EP4297708A4 (en) * 2021-09-09 2024-08-28 Samsung Electronics Co., Ltd. AUDIO CONTENT DELIVERY MANAGEMENT

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024983A (en) 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US4849222A (en) 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5288502A (en) 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
DE69431404T2 (de) 1993-10-22 2003-04-30 Genentech Inc., San Francisco Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
DE19528388A1 (de) * 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
WO1998010757A2 (en) * 1996-09-11 1998-03-19 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
JP3963488B2 (ja) * 1997-06-30 2007-08-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツンク ウント コンパニー コマンディゲゼルシャフト アウフ アクチェン １−アミノ−アルキルシクロヘキサンｎｍｄａ受容体拮抗薬
US6071966A (en) * 1997-06-30 2000-06-06 Merz + Co. Gmbh & Co. 1-amino-alkylcyclohexane NMDA receptor antagonists
HUP0300600A2 (hu) * 2000-04-26 2003-08-28 Warner-Lambert Co. Ciklohexil-amin-származékok mint altípus-szelektív NMDA receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
DE10048969A1 (de) * 2000-08-23 2002-03-14 Mueller Schwefe Gerhard Verwendung von Flupirtin zur Tinnitusbehandlung
US20030236288A1 (en) * 2002-02-28 2003-12-25 Karl Schoenafinger Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for inhibiting pancreatic lipase
JP2004021734A (ja) 2002-06-18 2004-01-22 Nokia Corp キーパッドおよびキーパッドシステム
US7086532B2 (en) * 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
JP2006502158A (ja) * 2002-09-06 2006-01-19 デュレクト コーポレーション グルタメート媒介神経伝達のモジュレーターの内耳への送達
DE10252665A1 (de) 2002-11-11 2004-06-03 Grünenthal GmbH 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
US20050014743A1 (en) * 2003-05-27 2005-01-20 Forest Laboratories, Inc. Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
AR046314A1 (es) 2003-11-05 2005-11-30 Merz Pharma Gmbh & Co Kgaa Composiciones que comprenden ciclohexilaminas y aminoadamantanos
US20060002999A1 (en) 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
ES2483126T3 (es) * 2004-06-17 2014-08-05 Merz Pharma Gmbh & Co. Kgaa Formulaciones de formas de dosificación de neramexano
US20060205822A1 (en) 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
EP1861161A4 (en) * 2005-01-24 2012-05-16 Neurosystec Corp APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
US20060205789A1 (en) * 2005-03-04 2006-09-14 Neurosystec Corporation Gacyclidine formulations
TWI265036B (en) * 2005-04-29 2006-11-01 Guo-Ming Huang Safety injector and method of operating the same
EP1898848B1 (en) * 2005-05-18 2010-11-24 GT Urological, LLC Drug elution for implantable incontinence devices
CN1896729A (zh) 2005-07-15 2007-01-17 复旦大学附属中山医院 纳米药物自组装双稳态量子线阵列及其制备方法
US20070141148A1 (en) 2005-11-30 2007-06-21 Merz Pharma Gmbh & Co. Kgaa Neramexane MR matrix tablet
TW200819458A (en) * 2006-06-23 2008-05-01 Merz Pharma Gmbh & Co Kgaa Metabotropic glutamate receptor modulators
TW200922544A (en) * 2007-09-12 2009-06-01 Merz Pharma Gmbh & Amp Co Kgaa Interval therapy for the treatment of tinnitus
TW201010691A (en) * 2008-06-12 2010-03-16 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
TW201006463A (en) * 2008-06-26 2010-02-16 Merz Pharma Gmbh & Co Kgaa Pharmaceutical compositions comprising aminocyclohexane derivatives
AU2009291244A1 (en) * 2008-09-10 2010-03-18 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
US20110294890A1 (en) * 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
JP6084931B2 (ja) * 2011-01-20 2017-02-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ストレス又は急性聴力損失に関連する耳鳴の治療又は予防のためのネラメキサン

Also Published As

Publication number Publication date
EP2200599A1 (en) 2010-06-30
JP5613053B2 (ja) 2014-10-22
HRP20120046T1 (hr) 2012-02-29
CA2699209A1 (en) 2009-03-19
AR070025A1 (es) 2010-03-10
ES2562709T3 (es) 2016-03-07
ES2596262T3 (es) 2017-01-05
US8877814B2 (en) 2014-11-04
SI2200600T1 (sl) 2012-03-30
JP5784189B2 (ja) 2015-09-24
JP2010539117A (ja) 2010-12-16
AU2008298015A1 (en) 2009-03-19
ES2377253T3 (es) 2012-03-23
AU2008298018B2 (en) 2012-01-19
US9498450B2 (en) 2016-11-22
EP2200599B1 (en) 2016-08-31
CA2699207A1 (en) 2009-03-19
ZA201001261B (en) 2011-08-31
EP2200600A1 (en) 2010-06-30
WO2009033650A1 (en) 2009-03-19
EP2548552A2 (en) 2013-01-23
AU2008298017B2 (en) 2012-03-01
AU2008298016A1 (en) 2009-03-19
ZA201001262B (en) 2011-07-27
TW200918042A (en) 2009-05-01
JP5563460B2 (ja) 2014-07-30
CN101801365A (zh) 2010-08-11
MX2010002734A (es) 2010-04-01
CN101801366A (zh) 2010-08-11
JP2010539115A (ja) 2010-12-16
US20150018425A1 (en) 2015-01-15
AU2008298016B2 (en) 2012-02-02
JP2010539118A (ja) 2010-12-16
KR20100052557A (ko) 2010-05-19
EP2386299B1 (en) 2016-07-13
DK2200600T3 (da) 2012-01-23
EP2548552B1 (en) 2015-11-18
US9468610B2 (en) 2016-10-18
AR071728A1 (es) 2010-07-14
KR20100052556A (ko) 2010-05-19
CN101795679A (zh) 2010-08-04
ES2604945T3 (es) 2017-03-10
EP2200600B1 (en) 2011-11-09
EP2386299A3 (en) 2012-05-02
TW200927087A (en) 2009-07-01
AU2008298017A1 (en) 2009-03-19
AU2008298018A1 (en) 2009-03-19
CA2699210A1 (en) 2009-03-19
JP5784188B2 (ja) 2015-09-24
JP2014221766A (ja) 2014-11-27
KR20100052559A (ko) 2010-05-19
EP2203163B1 (en) 2014-08-27
ATE532507T1 (de) 2011-11-15
BRPI0816712A2 (pt) 2016-11-08
CN101835469A (zh) 2010-09-15
MX2010002733A (es) 2010-04-09
BRPI0816690A2 (pt) 2016-11-01
JP5612473B2 (ja) 2014-10-22
CA2699213A1 (en) 2009-03-19
TW200922544A (en) 2009-06-01
JP2014221767A (ja) 2014-11-27
PT2200600E (pt) 2012-02-17
EP2386299A2 (en) 2011-11-16
WO2009033652A1 (en) 2009-03-19
US20100298440A1 (en) 2010-11-25
JP5563461B2 (ja) 2014-07-30
US20110077304A1 (en) 2011-03-31
US20100298441A1 (en) 2010-11-25
EP2200598A1 (en) 2010-06-30
JP2010539116A (ja) 2010-12-16
RU2011137131A (ru) 2013-03-20
US20110086916A1 (en) 2011-04-14
AU2008298018C1 (en) 2012-08-16
EP2548552A3 (en) 2013-10-16
ZA201001263B (en) 2011-07-27
ES2510565T3 (es) 2014-10-21
EP2203163A1 (en) 2010-07-07
MX2010002736A (es) 2010-04-01
ZA201001264B (en) 2011-07-27
PL2200600T3 (pl) 2012-04-30
WO2009033651A1 (en) 2009-03-19
KR20100052558A (ko) 2010-05-19
AU2008298015B2 (en) 2012-03-22
AR070026A1 (es) 2010-03-10
US20170027885A1 (en) 2017-02-02
WO2009033649A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
PH12015502628A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
PH12014500386A1 (en) Combination treatment for hepatitis c
MX377576B (es) Formulaciones de pridopidina de liberación modificada.
MX370543B (es) Profarmacos neutralizantes del factor de crecimiento endotelial vascular para el tratamiento de afecciones oculares.
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
MX2009013989A (es) Terapia en combinacion para depresion.
UA114726C2 (uk) 1,4-дизаміщені аналоги піридазину та способи лікування пов'язаних з дефіцитом smn станів
SG10201804552WA (en) Nanoparticle compositions, formulations thereof, and uses therefor
MX2015005798A (es) Terapia de combinacion.
ZA200907355B (en) Titration of tapentadol
HK1217191A1 (zh) 治療性化合物和其用途
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
WO2013003827A3 (en) Macrogol 15 hydroxystearate formulations
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
NZ744323A (en) Compositions comprising 15-hepe and methods of using the same
MX2015001917A (es) Composiciones farmaceuticas de memantina.
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
MY196425A (en) Indazole Compounds For Use In Tendon And/Or Ligament Injuries
MX2012012410A (es) Agente terapeutico y agente preventivo para enfermedad de alzheimer.
MX2010005009A (es) Uso de compuestos inmunomoduladores para el tratamiento de trastornos asociados con disfunciones endoteliales.
EA200801890A1 (ru) Средство для лечения шума в ушах
MX2009012761A (es) Neramexano para el tratamiento de nistagmo.